Total number Clinical Pharmacology Advisory Committee meetings and OCP Co-sponsor meetings (i.e. Drug Information Association (DIA), Pharmaceutical Research and Manufacturers of America (PhRMA)) that OCP co-organizes and presents per quarter

Main

Total number Clinical Pharmacology Advisory Committee meetings and OCP Co-sponsor meetings (i.e. Drug Information Association (DIA), Pharmaceutical Research and Manufacturers of America (PhRMA)) that OCP co-organizes and presents per quarterThese meetings with external parties are intended to resolve equivocal scientific issues that lead to clear policy for industry.<br>This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b>

Number

2010

Measure was implemented starting February 2010

Feb 20101Mar 20101Apr 20100May 20100Jun 20101Jul 20100Aug 20100Sep 20101

http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER Dashboard